Login

Richard Garr, President & CEO of Neuralstem Inc 00:00:00

Share On Facebook Share On Twitter

Neuralstem Inc

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Yukikazu Myochin, CEO of "K" LINE, Named in CDP2022 'A List' Companies | Yukikazu Myochin - CEO of kawasaki kisen kaisha ltd
00:10:00
Maria Edsman, CEO of Bokusgruppen, on Growth, Strategy, and the Future of Reading | Maria Edsman, CEO, Bokusgruppen AB.
00:10:00
GLG's Company Culture Rated C+ with CEO Paul Todd Scoring D+
00:10:00
The best and only way to get on Beta Boom's radar is to fill out their 3-minute intake|Sergio Paluch,Managing Partner,Beta Boom
00:10:00
The Shattering of American Liberalism: From JFK to Carter|James Pierson
00:10:00
Innovative Hiring for Long-term Employee Retention and Success with Yonhee Choi Gordon | Yonhee Choi Gordon, CFP®, JMG Financial Group
00:00:00
Judith Greciet , CEO, Onxeo
00:10:00
ATA188: an EBV-specific T cell allogeneic treatment for MS progression | Pascal Touchon, PRESIDENT AND CHIEF EXECUTIVE OFFICER, ATARA BIOTHERAPEUTICS INC
00:10:00
Exclusive Interview with ATFX Chairman Joe Lee at IFX Expo: Technological Innovations and Strategic Vision
00:10:00
Dean Minow in Conversation with Kim Koopersmith: Legal Insights | Kim Koopersmith - Partner & Chairperson of akin gump strauss hauer & feld llp
00:10:00
Sitowise Group: A Leader in Construction, Infrastructure, and Sustainability with CEO Heikki Haasmaa | Heikki Haasma, CEO, Sitowise Group Oyj.
00:10:00
Navigating the Future: Cablevision's Transformation and the Multi-Screen World | Josh Sapan, CEO, AMC Networks Inc.

© 2017 - Neuhu+